In this podcast developed by Biotechniques, our Lead Scientist Gareth Guenigault discussed NAFLD & NASH and their growing prevalence both in terms of cases and economic factors.

Gareth then discusses how our Liver-on-a-chip model and our new NASH-in-a-box kit are helping in the fight to find an approved therapeutic treatment.